BlackRock Group LTD - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 124 filers reported holding NEWLINK GENETICS CORP in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2016$102,000
-26.1%
9,858
+8.1%
0.00%
Q3 2016$138,000
+11.3%
9,123
-17.1%
0.00%
Q2 2016$124,000
-38.9%
11,000
-0.9%
0.00%
Q1 2016$203,000
-32.1%
11,105
+35.0%
0.00%
Q4 2015$299,000
+20.1%
8,226
+18.3%
0.00%
Q3 2015$249,000
+0.4%
6,953
+24.2%
0.00%
Q2 2015$248,000
+90.8%
5,598
+135.5%
0.00%
Q1 2015$130,000
+140.7%
2,377
+73.6%
0.00%
Q4 2014$54,000
+107.7%
1,369
+10.8%
0.00%
Q3 2014$26,000
+30.0%
1,236
+67.0%
0.00%
Q2 2014$20,000
-88.4%
740
-87.8%
0.00%
Q1 2014$173,0006,0870.00%
Other shareholders
NEWLINK GENETICS CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 93,533$962,0001.69%
WALL STREET ASSOCIATES 108,900$1,119,0000.74%
NORTHWEST WEALTH MANAGEMENT, LLC 57,482$591,0000.60%
Orbimed Advisors 1,991,700$20,475,0000.26%
TFS CAPITAL LLC 92,041$946,0000.25%
Intrinsic Edge Capital Management LLC 40,000$411,0000.18%
SECOR Capital Advisors, LP 100,529$1,033,0000.13%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 176,077$1,810,0000.12%
Piermont Capital Management Inc. 41,400$426,0000.10%
Vident Investment Advisory, LLC 67,209$691,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders